BIOGEN® Laboratories is a Colombian pharmaceutical company, which fabricates and commercializes high quality medicine, for various fundamental therapeutical actions, developed within the innovation and investigation fields. The result: the patient’s wellbeing and the growth of the company in the market.
In June 4 of 1980, the pharmaceutical company Laboratorios Biogen de Colombiana, was constituted in the City of Bogotá, and started maketing two successful products Ampicyl (ampicillin) and Biomizol (mebendazole).
Today the company has more than 200 products manufactured and marketed, in various Lines Consumption and Farma.
In 1990, BIOGEN’s main headquarters open. That year already, the company would strongly position itself within the market, with important products such as, Acibiogel (aluminium hydroxide), Stopen (Piroxicam), Virex (Acyclovir) and Pilogan (Minoxidil).
In the late 90’s BIOGEN’s growth is vertiginous. Its new headquarters, its multiple business lines (Farma, OTC, Veterinary, Genericios, Hospitable), the positioning of big brands, the national coverture and the incursion in foreign markets, would consolidate the company within the industry.
In 2014, BIOGEN and GRÜNENTHAL, establish an alliance to strengthen the German company’s position in Latin America. The European multinational incorporates a portfolio with 30 products of some of BIOGEN’s most important brands, such as antivirals, anti-inflammatories, gynecological and respiratory.
To contribute to patients’ healthcare with safety and ethical responsibility, in areas where the expansion of the brand and its products is possible, always with an innovative, technological and competitive policy.